Incannex Healthcare gains ethics green light for Phase 2 clinical trial assessing IHL-675A as rheumatoid arthritis treatment

Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) is preparing to advance its clinical trial assessing the treatment of rheumatoid arthritis to the second...

Related Keywords

New Zealand ,Camberwell ,Victoria ,Australia ,Australian ,Mark Bleackley ,Nasdaq ,Incannex Healthcare Ltd ,Human Research Ethics Committees ,Emeritus Research ,Avance Clinical ,